Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Hormonal.
Formula:
Each 100 mL contains:
Buserelin acetate 0.00042 g
Formulation agents q.s.
Indications:
Cows: Treatment of ovarian-origin fertility disorders: follicular cysts, acyclicity, anestrus, delayed ovulation, and follicular atresia. Increases conception rates in artificial insemination and after estrus synchronization.
Mares: Treatment of ovarian cystic disorders, with or without prolonged or persistent estrus; and acyclicity. Induction of ovulation (in prolonged or persistent estrus, to fix the time of ovulation and breeding, improving conception rates).
Target Species:
Cattle and equines.
Administration:
Intramuscular, subcutaneous, or intravenous route.
Dosage:
Cows:
Follicular cysts, acyclicity, and anestrus: 5 mL.
Delayed ovulation, follicular atresia, increased conception rate in artificial insemination and after estrus synchronization: 2.5 mL.
Mares:
Ovarian cystic disorders, with or without prolonged or persistent estrus; ovulation induction and breeding; improvement of conception rate; prolonged or persistent estrus: 10 mL.
Acyclicity: two doses of 5 mL, 24 hours apart.
Presentation:
Vial containing 50 mL of net content. Box with 12 vials of 10 mL net content each.
Hormonal.
Formula:
Each 100 mL contains:
Buserelin acetate 0.00042 g
Formulation agents q.s.
Indications:
Cows: Treatment of ovarian-origin fertility disorders: follicular cysts, acyclicity, anestrus, delayed ovulation, and follicular atresia. Increases conception rates in artificial insemination and after estrus synchronization.
Mares: Treatment of ovarian cystic disorders, with or without prolonged or persistent estrus; and acyclicity. Induction of ovulation (in prolonged or persistent estrus, to fix the time of ovulation and breeding, improving conception rates).
Target Species:
Cattle and equines.
Administration:
Intramuscular, subcutaneous, or intravenous route.
Dosage:
Cows:
Follicular cysts, acyclicity, and anestrus: 5 mL.
Delayed ovulation, follicular atresia, increased conception rate in artificial insemination and after estrus synchronization: 2.5 mL.
Mares:
Ovarian cystic disorders, with or without prolonged or persistent estrus; ovulation induction and breeding; improvement of conception rate; prolonged or persistent estrus: 10 mL.
Acyclicity: two doses of 5 mL, 24 hours apart.
Presentation:
Vial containing 50 mL of net content. Box with 12 vials of 10 mL net content each.
